Increased isolevuglandin-modified proteins in glaucomatous astrocytes

Bharathi Govindarajan, Anna Junk, Mabel Algeciras, Robert G. Salomon, Sanjoy K. Bhattacharya

Research output: Contribution to journalArticlepeer-review

19 Scopus citations


Purpose: Lipid oxidation has been proposed to be a factor in the pathophysiology of glaucoma. We investigated whether elevated levels of isolevuglandin (iso[4]LGE2) protein adducts are associated with astrocytes derived from the glaucomatous optic nerve head. In addition, we examined whether the iso[4]LGE2 protein adducts are altered following exposure of astrocytes to elevated pressure. Methods: Astrocytes were isolated from rat brain cortex and human optic nerve and were subjected to pressure treatments, western blot analyses, liquid chromatography tandem mass spectrometry, and immunocytochemistry. Results: Elevated levels of isolevuglandin (iso[4]LGE2) protein adducts were associated with astrocytes derived from the glaucomatous (n=10) optic nerve head when compared to those from controls (n=6). Astrocytes subjected to in vitro pressure treatment resulted in increased levels of iso[4]LGE2 protein adducts. Pressure exposure and the recovery period affect iso[4]LGE2 protein modification, and pyridoxamine was effective in decreasing the appearance of iso[4]LGE2 protein adduct immunoreactivity when applied immediately after pressure treatment. Conclusions: These results suggest that the elevated iso[4]LGE2 protein adduct immunoreactivity observed in glaucomatous astrocytes may be due to chronic and/or prolonged exposure to pressure, and pyridoxamine may have prophylactic utility against such oxidative protein modification.

Original languageEnglish (US)
Pages (from-to)1079-1091
Number of pages13
JournalMolecular vision
StatePublished - Jun 1 2009

ASJC Scopus subject areas

  • Ophthalmology


Dive into the research topics of 'Increased isolevuglandin-modified proteins in glaucomatous astrocytes'. Together they form a unique fingerprint.

Cite this